Confluent [CFLT] vs Oracle [ORCL] Detailed Stock Comparison
Confluent
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Confluent wins in 9 metrics, Oracle wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Confluent | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -15.26 | 58.19 | Confluent |
| Price-to-Book Ratio | 5.41 | 34.66 | Confluent |
| Debt-to-Equity Ratio | 104.15 | 519.59 | Confluent |
| PEG Ratio | 47.81 | 35.27 | Oracle |
| EV/EBITDA | -13.68 | 34.39 | Confluent |
| Profit Margin (TTM) | -29.28% | 21.68% | Oracle |
| Operating Margin (TTM) | -34.16% | 32.48% | Oracle |
| EBITDA Margin (TTM) | N/A | 32.48% | N/A |
| Return on Equity | -32.18% | 82.38% | Oracle |
| Return on Assets (TTM) | -9.28% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $9.49M | $-394.00M | Confluent |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | -16.68% | 94.18% | Oracle |
| Price-to-Sales Ratio (TTM) | 5.42 | 12.36 | Confluent |
| Enterprise Value | $5.11B | $807.58B | Oracle |
| EV/Revenue Ratio | 4.80 | 14.07 | Confluent |
| Gross Profit Margin (TTM) | 73.73% | 70.19% | Confluent |
| Revenue per Share (TTM) | $3 | $21 | Oracle |
| Earnings per Share (Diluted) | $-0.93 | $4.34 | Oracle |
| Beta (Stock Volatility) | 0.96 | 1.43 | Confluent |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Confluent vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Confluent | -3.54% | -4.51% | -34.43% | -17.13% | -43.60% | -40.07% |
| Oracle | 0.28% | -1.73% | 7.38% | 66.96% | 42.95% | 50.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Confluent | -16.68% | -49.16% | -63.32% | -63.32% | -63.32% | -63.32% |
| Oracle | 94.18% | 223.98% | 373.12% | 550.67% | 1,031.64% | 1,828.05% |
Performance & Financial Health Analysis: Confluent vs Oracle
| Metric | CFLT | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $5.77B | $709.31B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 13,438,025 | 9,447,430 |
| 90 Day Avg. Volume | 7,968,922 | 13,061,150 |
| Last Close | $16.33 | $250.10 |
| 52 Week Range | $16.19 - $37.90 | $118.86 - $260.87 |
| % from 52W High | -56.91% | -4.13% |
| All-Time High | $94.97 (Nov 01, 2021) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -82.81% | -4.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.11% |
| Quarterly Earnings Growth | 0.20% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.29% | 0.22% |
| Operating Margin (TTM) | -0.34% | 0.32% |
| Return on Equity (TTM) | -0.32% | 0.82% |
| Debt to Equity (MRQ) | 104.15 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.09 | $7.29 |
| Cash per Share (MRQ) | $5.63 | $3.99 |
| Operating Cash Flow (TTM) | $42.19M | $20.82B |
| Levered Free Cash Flow (TTM) | $174.88M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Confluent vs Oracle
| Metric | CFLT | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -15.26 | 58.19 |
| Forward P/E | 47.81 | 35.27 |
| PEG Ratio | 47.81 | 35.27 |
| Price to Sales (TTM) | 5.42 | 12.36 |
| Price to Book (MRQ) | 5.41 | 34.66 |
| Market Capitalization | ||
| Market Capitalization | $5.77B | $709.31B |
| Enterprise Value | $5.11B | $807.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.80 | 14.07 |
| Enterprise to EBITDA | -13.68 | 34.39 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.43 |
| Book Value per Share (MRQ) | $3.09 | $7.29 |
Financial Statements Comparison: Confluent vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CFLT | ORCL |
|---|---|---|
| Revenue/Sales | $282.29M | $15.90B |
| Cost of Goods Sold | $74.17M | $4.74B |
| Gross Profit | $208.12M | $11.16B |
| Research & Development | $121.22M | $2.65B |
| Operating Income (EBIT) | $-96.44M | $5.19B |
| EBITDA | $-89.09M | $7.00B |
| Pre-Tax Income | $-75.33M | $4.15B |
| Income Tax | $6.62M | $725.00M |
| Net Income (Profit) | $-81.95M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CFLT | ORCL |
|---|---|---|
| Cash & Equivalents | $278.56M | $10.79B |
| Total Current Assets | $2.34B | $24.58B |
| Total Current Liabilities | $529.87M | $32.64B |
| Long-Term Debt | $1.10B | $96.83B |
| Total Shareholders Equity | $1.03B | $20.97B |
| Retained Earnings | $-2.06B | $-15.48B |
| Property, Plant & Equipment | $7.92M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CFLT | ORCL |
|---|---|---|
| Operating Cash Flow | $28.41M | $5.93B |
| Capital Expenditures | $-1.43M | N/A |
| Free Cash Flow | $-32.99M | $-2.92B |
| Debt Repayment | N/A | $-6.07B |
| Common Stock Repurchase | N/A | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CFLT | ORCL |
|---|---|---|
| Shares Short | 22.34M | 20.68M |
| Short Ratio | 4.12 | 1.27 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 13,438,025 | 9,447,430 |
| Average Daily Volume (90 Day) | 7,968,922 | 13,061,150 |
| Shares Outstanding | 332.89M | 2.81B |
| Float Shares | 280.61M | 1.64B |
| % Held by Insiders | 0.04% | 0.42% |
| % Held by Institutions | 0.94% | 0.45% |
Dividend Analysis & Yield Comparison: Confluent vs Oracle
| Metric | CFLT | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |